Manulife (Manufacturers Life Insurance)
LEGN icon

Manulife (Manufacturers Life Insurance)’s Legend Biotech LEGN Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$188K Buy
10,393
+570
+6% +$10.9K ﹤0.01% 2480
2025
Q4 		$214K Sell
9,823
-885
-8% -$25.4K ﹤0.01% 2499
2025
Q3 		$349K Sell
10,708
-73,373
-87% -$2.71M ﹤0.01% 2331
2025
Q2 		$2.98M Buy
84,081
+11,771
+16% +$381K ﹤0.01% 1357
2025
Q1 		$2.45M Sell
72,310
-4,483
-6% -$161K ﹤0.01% 1409
2024
Q4 		$2.5M Sell
76,793
-205
-0.3% -$8.49K ﹤0.01% 1473
2024
Q3 		$3.75M Sell
76,998
-9,412
-11% -$501K ﹤0.01% 1333
2024
Q2 		$3.83M Sell
86,410
-466,003
-84% -$21.5M ﹤0.01% 1277
2024
Q1 		$31M Sell
552,413
-56,582
-9% -$3.41M 0.03% 481
2023
Q4 		$36.6M Buy
608,995
+18,525
+3% +$1.17M 0.02% 440
2023
Q3 		$39.7M Sell
590,470
-2,545
-0.4% -$177K 0.02% 382
2023
Q2 		$40.9M Buy
593,015
+63,404
+12% +$4.14M 0.02% 381
2023
Q1 		$25.5M Buy
529,611
+21,022
+4% +$1.03M 0.01% 535
2022
Q4 		$25.4M Buy
508,589
+5,579
+1% +$270K 0.02% 511
2022
Q3 		$20.5M Buy
503,010
+4,728
+0.9% +$222K 0.01% 578
2022
Q2 		$27.4M Buy
498,282
+27,280
+6% +$1.15M 0.02% 486
2022
Q1 		$17.1M Buy
471,002
+221,134
+89% +$8.74M 0.01% 707
2021
Q4 		$12K Sell
249,868
-79,500
-24% -$4.03M 0.01% 857
2021
Q3 		$16.7M Hold
329,368
– – 0.01% 733
2021
Q2 		$13.5M Hold
329,368
– – 0.01% 831
2021
Q1 		$9.56M Buy
+329,368
New +$8.98M 0.01% 978

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FBIL
First Beijing Investment Ltd Hong Kong $2.32B AUM 8.06% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s LEGN Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) increased its Legend Biotech (LEGN) stake by 5.8% in Q1 2026, buying an estimated $10.9K and bringing the position to 10,393 shares worth $188K. The position accounts for ﹤0.01% of the portfolio, ranked #2480.

Manulife (Manufacturers Life Insurance) first reported a position in LEGN in Q1 2021 and has held it in 21 quarters since. The position peaked at $40.9M in Q2 2023. 190 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 10,393 shares of Legend Biotech worth $188K as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) bought 570 Legend Biotech shares in Q1 2026, an estimated $10.9K.
  • Legend Biotech made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #2480 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Legend Biotech in Q1 2021 and has held it in 21 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Legend Biotech position peaked at $40.9M in Q2 2023.
  • 190 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.